ALLO ▲ +0.8% - Allogene Therapeutics, Inc.
$ALLO - Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data
29-OCT-2026 08:30 AM ET
Share this post
More filings for $ALLO
ALLO - Allogene Therapeutics, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026ALLO - Allogene Therapeutics, Inc. - SEC Filing Update (30-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 30, 2026ALLO ▼ -2.0% - Allogene Therapeutics, Inc.Sep 2, 2026ALLO - Allogene Therapeutics, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026ALLO - Allogene Therapeutics, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 8, 2026
View full $ALLO filing history →💬 Comments
Loading comments…
Leave a comment